{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:58:16Z","timestamp":1769119096341,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clinbiochem.2022.04.005","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T02:47:23Z","timestamp":1649904443000},"page":"75-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancy"],"prefix":"10.1016","volume":"105-106","author":[{"given":"Susan","family":"Ashrafzadeh-Kian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Bornhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.clinbiochem.2022.04.005_b0005","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer","volume":"322","author":"Burtis","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.04.005_b0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clinchem\/39.3.414","article-title":"Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein","volume":"39","author":"Fraser","year":"1993","journal-title":"Clin. Chem"},{"issue":"9","key":"10.1016\/j.clinbiochem.2022.04.005_b0015","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone-related protein: an update","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2022.04.005_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cca.2008.12.040","article-title":"The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia","volume":"402","author":"Fritchie","year":"2009","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.04.005_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0889-8529(18)30376-1","article-title":"Etiologies and therapy of hypercalcemia","volume":"18","author":"Bilezikian","year":"1989","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.04.005_b0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"Pt 3","key":"10.1016\/j.clinbiochem.2022.04.005_b0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/000456329102800305","article-title":"Hypercalcaemia due to calcium binding by a polymeric IgA kappa-paraprotein","volume":"28","author":"Pearce","year":"1991","journal-title":"Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.clinbiochem.2022.04.005_b0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jc.2005-2095","article-title":"Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene","volume":"91","author":"VanHouten","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.04.005_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcu166","article-title":"Use of denosumab in parathyroid carcinoma with refractory hypercalcemia","volume":"108","author":"Tong","year":"2015","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.04.005_b0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1373\/clinchem.2015.244012","article-title":"LC-MS\/MS Measurement of Parathyroid Hormone-Related Peptide","volume":"62","author":"Kushnir","year":"2016","journal-title":"Clin. Chem"},{"key":"10.1016\/j.clinbiochem.2022.04.005_b0055","first-page":"52","article-title":"Protocols for determination of limits of detection and limits of quantitation","volume":"17","author":"Tholen","year":"2004","journal-title":"Approved Guideline."},{"issue":"3","key":"10.1016\/j.clinbiochem.2022.04.005_b0060","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0021-9258(18)52390-5","article-title":"Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone","volume":"266","author":"Cohen","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.04.005_b0065","first-page":"40","article-title":"Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions","volume":"15","author":"Orloff","year":"1994","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.04.005_b0070","first-page":"384","article-title":"Parathyroid-hormone-related peptide immunochemiluminometric assay. Developed with polyclonal antisera produced from a single animal","volume":"27","author":"Wu","year":"1997","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.04.005_b0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1257\/jep.15.4.143","article-title":"Quantile Regression","volume":"15","author":"Koenker","year":"2001","journal-title":"J. Econ. Perspectives"},{"issue":"5","key":"10.1016\/j.clinbiochem.2022.04.005_b0080","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update","volume":"60","author":"National Kidney","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.clinbiochem.2022.04.005_b0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple hypothesis testing","volume":"B","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.04.005_b0090","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ki.1993.193","article-title":"Accumulation of carboxy-terminal fragments of parathyroid hormone-related protein in renal failure","volume":"43","author":"Orloff","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinbiochem.2022.04.005_b0095","doi-asserted-by":"crossref","unstructured":"Pandian, M.R., et al., Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia. Clin. Chem, 1992. 38(2): p. 282-8.","DOI":"10.1093\/clinchem\/38.2.282"},{"issue":"1","key":"10.1016\/j.clinbiochem.2022.04.005_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/000456329403100106","article-title":"In vitro stability of endogenous parathyroid hormone-related protein in blood and plasma","volume":"31","author":"Hutchesson","year":"1994","journal-title":"Ann. Clin. Biochem."},{"issue":"12","key":"10.1016\/j.clinbiochem.2022.04.005_b0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/LM23TD4IUTAJBJMG","article-title":"Falsely elevated parathyroid hormone-related protein (pth-rp) in a patient with hypercalcemia and renal failure","volume":"42","author":"Lum","year":"2011","journal-title":"Laboratory Medicine"},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.04.005_b0110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.clinbiochem.2022.04.005_b0115","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2009.11","article-title":"Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors","volume":"75","author":"Poggio","year":"2009","journal-title":"Kidney Int."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912022001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:59:08Z","timestamp":1757865548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912022001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":23,"alternative-id":["S0009912022001035"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.04.005","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancy","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}